Notably, a meta-analysis of molecular imaging of SERT and biochemical post-mortem findings from depression patients revealed reduced SERT in the amygdala and enhanced binding in the hippocampus [70,71]. This evidence concerns the gene SLC6A4 and depressive disorder.